BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 23486537)

  • 41. Identification of novel common breast cancer risk variants at the 6q25 locus among Latinas.
    Hoffman J; Fejerman L; Hu D; Huntsman S; Li M; John EM; Torres-Mejia G; Kushi L; Ding YC; Weitzel J; Neuhausen SL; Lott P; ; Echeverry M; Carvajal-Carmona L; Burchard E; Eng C; Long J; Zheng W; Olopade O; Huo D; Haiman C; Ziv E
    Breast Cancer Res; 2019 Jan; 21(1):3. PubMed ID: 30642363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TOX high mobility group box family member 3 rs3803662 and breast cancer risk: A meta-analysis.
    Li L; Guo G; Wang F; Lv P; Zhu M; Gu Y; Han M; Pei X
    J Cancer Res Ther; 2018; 14(Supplement):S208-S212. PubMed ID: 29578175
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low-penetrance susceptibility variants and postmenopausal oestrogen receptor positive breast cancer.
    Özgöz A; İçduygu FM; Yükseltürk A; ŞamlI H; Öztürk KH; Başkan Z
    J Genet; 2020; 99():. PubMed ID: 32366738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women.
    Barnholtz-Sloan JS; Shetty PB; Guan X; Nyante SJ; Luo J; Brennan DJ; Millikan RC
    Carcinogenesis; 2010 Aug; 31(8):1417-23. PubMed ID: 20554749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1.
    Zheng W; Long J; Gao YT; Li C; Zheng Y; Xiang YB; Wen W; Levy S; Deming SL; Haines JL; Gu K; Fair AM; Cai Q; Lu W; Shu XO
    Nat Genet; 2009 Mar; 41(3):324-8. PubMed ID: 19219042
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validation of associations between ESR1 variants and breast cancer risk in Chinese cohorts.
    Li X; Yao GY; Li FX; Qiu YR; Yang XX
    Genet Mol Res; 2016 Jul; 15(3):. PubMed ID: 27525837
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of germline variation in CCNE1 and CDK2 with breast cancer risk, progression and survival among Chinese Han women.
    Han JY; Wang H; Xie YT; Li Y; Zheng LY; Ruan Y; Song AP; Tian XX; Fang WG
    PLoS One; 2012; 7(11):e49296. PubMed ID: 23185313
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of ESR1 Polymorphisms on Risk of Breast Cancer in the Chinese Han Population.
    Yang W; He X; He C; Peng L; Xing S; Li D; Wang L; Jin T; Yuan D
    Clin Breast Cancer; 2021 Jun; 21(3):e235-e242. PubMed ID: 33281037
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.
    Agarwal D; Pineda S; Michailidou K; Herranz J; Pita G; Moreno LT; Alonso MR; Dennis J; Wang Q; Bolla MK; Meyer KB; Menéndez-Rodríguez P; Hardisson D; Mendiola M; González-Neira A; Lindblom A; Margolin S; Swerdlow A; Ashworth A; Orr N; Jones M; Matsuo K; Ito H; Iwata H; Kondo N; ; ; Hartman M; Hui M; Lim WY; Iau PT; Sawyer E; Tomlinson I; Kerin M; Miller N; Kang D; Choi J-; Park SK; Noh D-; Hopper JL; Schmidt DF; Makalic E; Southey MC; Teo SH; Yip CH; Sivanandan K; Tay W-; Brauch H; Brüning T; Hamann U; ; Dunning AM; Shah M; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Schmidt MK; Broeks A; Rosenberg EH; van't Veer LJ; Fasching PA; Renner SP; Ekici AB; Beckmann MW; Shen C-; Hsiung C-; Yu J-; Hou M-; Blot W; Cai Q; Wu AH; Tseng C-; Van Den Berg D; Stram DO; Cox A; Brock IW; Reed MW; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Zheng W; Deming-Halverson S; Shrubsole MJ; Long J; Shu X-; Lu W; Gao Y-; Zhang B; Radice P; Peterlongo P; Manoukian S; Mariette F; Sangrajrang S; McKay J; Couch FJ; Toland AE; ; Yannoukakos D; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Marme F; Burwinkel B; Guénel P; Truong T; Sanchez M; Mulot C; Bojesen SE; Nordestgaard BG; Flyer H; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Mannermaa A; Kataja V; Kosma V-; Hartikainen JM; Lambrechts D; Yesilyurt BT; Floris G; Leunen K; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Wang X; Olson JE; Vachon C; Purrington K; Giles GG; Severi G; Baglietto L; Haiman CA; Henderson BE; Schumacher F; Marchand LL; Simard J; Dumont M; Goldberg MS; Labréche F; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Devilee P; Tollenaar RA; Seynaeve C; García-Closas M; Chanock SJ; Lissowska J; Figueroa JD; Czene K; Eriksson M; Humphreys K; Darabi H; Hooning MJ; Kriege M; Collée JM; Tilanus-Linthorst M; Li J; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Bogdanova N; Dörk T; Hall P; Chenevix-Trench G; Easton DF; Pharroah PD; Arias-Perez JI; Zamora P; Benítez J; Milne RL
    Br J Cancer; 2014 Feb; 110(4):1088-100. PubMed ID: 24548884
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markers.
    Zheng Y; Ogundiran TO; Falusi AG; Nathanson KL; John EM; Hennis AJ; Ambs S; Domchek SM; Rebbeck TR; Simon MS; Nemesure B; Wu SY; Leske MC; Odetunde A; Niu Q; Zhang J; Afolabi C; Gamazon ER; Cox NJ; Olopade CO; Olopade OI; Huo D
    Carcinogenesis; 2013 Jul; 34(7):1520-8. PubMed ID: 23475944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry.
    Cai Q; Wen W; Qu S; Li G; Egan KM; Chen K; Deming SL; Shen H; Shen CY; Gammon MD; Blot WJ; Matsuo K; Haiman CA; Khoo US; Iwasaki M; Santella RM; Zhang L; Fair AM; Hu Z; Wu PE; Signorello LB; Titus-Ernstoff L; Tajima K; Henderson BE; Chan KY; Kasuga Y; Newcomb PA; Zheng H; Cui Y; Wang F; Shieh YL; Iwata H; Le Marchand L; Chan SY; Shrubsole MJ; Trentham-Dietz A; Tsugane S; Garcia-Closas M; Long J; Li C; Shi J; Huang B; Xiang YB; Gao YT; Lu W; Shu XO; Zheng W
    Cancer Res; 2011 Feb; 71(4):1344-55. PubMed ID: 21303983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low-risk variants FGFR2, TNRC9 and LSP1 in German familial breast cancer patients.
    Hemminki K; Müller-Myhsok B; Lichtner P; Engel C; Chen B; Burwinkel B; Försti A; Sutter C; Wappenschmidt B; Hellebrand H; Illig T; Arnold N; Niederacher D; Dworniczak B; Deissler H; Kast K; Gadzicki D; Meitinger T; Wichmann HE; Kiechle M; Bartram CR; Schmutzler RK; Meindl A
    Int J Cancer; 2010 Jun; 126(12):2858-62. PubMed ID: 19856316
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk of GWAS-identified genetic variants for breast cancer in a Chinese population: a multiple interaction analysis.
    Chen W; Song H; Zhong R; Zhu B; Guo H; Lou J; Shen N; Li J; Chen X; Liu C; Ming J; Huang T; Miao X
    Breast Cancer Res Treat; 2013 Dec; 142(3):637-44. PubMed ID: 24265035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls.
    Zheng W; Zhang B; Cai Q; Sung H; Michailidou K; Shi J; Choi JY; Long J; Dennis J; Humphreys MK; Wang Q; Lu W; Gao YT; Li C; Cai H; Park SK; Yoo KY; Noh DY; Han W; Dunning AM; Benitez J; Vincent D; Bacot F; Tessier D; Kim SW; Lee MH; Lee JW; Lee JY; Xiang YB; Zheng Y; Wang W; Ji BT; Matsuo K; Ito H; Iwata H; Tanaka H; Wu AH; Tseng CC; Van Den Berg D; Stram DO; Teo SH; Yip CH; Kang IN; Wong TY; Shen CY; Yu JC; Huang CS; Hou MF; Hartman M; Miao H; Lee SC; Putti TC; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Sangrajrang S; Shen H; Chen K; Wu PE; Ren Z; Haiman CA; Sueta A; Kim MK; Khoo US; Iwasaki M; Pharoah PD; Wen W; Hall P; Shu XO; Easton DF; Kang D
    Hum Mol Genet; 2013 Jun; 22(12):2539-50. PubMed ID: 23535825
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single nucleotide polymorphisms associated with female breast cancer susceptibility in Chinese population.
    Jia Z; Huang Y; Liu J; Liu G; Li J; Xu H; Jiang Y; Zhang S; Wang Y; Chen G; Qiao G; Li Y
    Gene; 2023 Oct; 884():147676. PubMed ID: 37524136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women.
    Zheng W; Wen W; Gao YT; Shyr Y; Zheng Y; Long J; Li G; Li C; Gu K; Cai Q; Shu XO; Lu W
    J Natl Cancer Inst; 2010 Jul; 102(13):972-81. PubMed ID: 20484103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polymorphisms in second intron of the FGFR2 gene are associated with the risk of early-onset breast cancer in Chinese Han women.
    Fu F; Wang C; Huang M; Song C; Lin S; Huang H
    Tohoku J Exp Med; 2012 Mar; 226(3):221-9. PubMed ID: 22374580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Admixture mapping identifies a locus on 6q25 associated with breast cancer risk in US Latinas.
    Fejerman L; Chen GK; Eng C; Huntsman S; Hu D; Williams A; Pasaniuc B; John EM; Via M; Gignoux C; Ingles S; Monroe KR; Kolonel LN; Torres-Mejía G; Pérez-Stable EJ; Burchard EG; Henderson BE; Haiman CA; Ziv E
    Hum Mol Genet; 2012 Apr; 21(8):1907-17. PubMed ID: 22228098
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diverse associations between ESR1 polymorphism and breast cancer development and progression.
    Ding SL; Yu JC; Chen ST; Hsu GC; Hsu HM; Ho JY; Lin YH; Chang CC; Fann CS; Cheng CW; Wu PE; Shen CY
    Clin Cancer Res; 2010 Jul; 16(13):3473-84. PubMed ID: 20570923
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heterogeneity of Breast Cancer Associations with Common Genetic Variants in FGFR2 according to the Intrinsic Subtypes in Southern Han Chinese Women.
    Liang H; Yang X; Chen L; Li H; Zhu A; Sun M; Wang H; Li M
    Biomed Res Int; 2015; 2015():626948. PubMed ID: 26421298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.